top of page

Female-Founded Antheia Raises $73 Million to Support Synthetic Biology for Essential Medicines

Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and support the production of necessary active pharmaceutical ingredients and materials.

Read the article at:

bottom of page